Here's a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

Published Wed, Oct 11 20234:43 PM EDT

Kevin Stankiewicz @in/kevin-stankiewicz-b5593466 @kevin_stank

Here's a rapid-fire update on all stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. Jim ran through each stock Wednesday during our October Monthly Meeting. Apple (AAPL): Our "own it, don't trade it" mantra on Apple has served us well over the years, and there's been no change to that approach amid the stock's up-and-down ride since August. While there will always be noise surrounding the iPhone maker, blocking it out has proved to be the right move for long-term investors like us. Amazon (AMZN): The Federal Trade Commission's antitrust lawsuit against the e-commerce and cloud-computing giant doesn't shake our investment thesis . After reducing expenses to improve margins on its retail business, Jim said it's on the right track. Broadcom (AVGO): Jim said Broadcom shares should be bought before the company's megadeal for data-center software firm VMWare (VMW) closes. If that happens, Broadcom should eventually command a higher valuation thanks to a larger software business. If Chinese regulators stand in the way, Broadcom will have the firepower to do something like a massive buyback program, Jim said. Bausch Health (BHC): While we're still not recommending investors buy additional Bausch Health shares, the troubled Canadian pharmaceutical firm's potential path to recovery has become increasingly clear. To be sure, it's a gauntlet, and multiple things need to go right, especially its Xifaxan patent litigation. We still have a 4 rating on the stock. Caterpillar (CAT): Caterpillar's summer rally faded in September and into October, but we're not concerned about the industrial giant's standing. For the year, the stock is up about 13%. The flood of federal infrastructure spending remains a major tailwind for Caterpillar. Costco Wholesale (COST): Costco remains one of Jim's favorite stocks in the entire our entire portfolio. The prospect of a special dividend remains just a matter of time, though we recognize it may be further out on the horizon now because Costco can a lot more interest on the cash that would be used to pay it. The wholesale retailer reported strong fiscal 2023 Q4 results on Sept. 26. Salesforce (CRM): Salesforce's more-than-8% drop over the past month doesn't reflect the strength of the company's current business and future opportunities tied to emerging artificial intelligence initiatives. We've been impressed with the enterprise software maker's ability to deliver double-digit percentage revenue growth while lifting margins. Coterra Energy (CTRA): Jim said Coterra is an important piece to our portfolio, and lately has been a big winner. Over the past five days, the stock has jumped about 9% as natural gas prices have climbed. It's worth noting that Exxon Mobil 's planned acquisition of Club holding Pioneer Natural Resources (more on that deal below) has put energy industry consolidation back in the spotlight. Dupont (DD): A serial buyer of its own stock, Dupont's exposure to a diverse set of industrial end markets helped convince us to add the company to our portfolio in August . The company is doing well now, Jim said. But a stronger economy would translate into even better numbers. Danaher (DHR): Danaher's transformation into a pure-play life sciences firm should translate into a higher valuation, but that hasn't happened yet despite the recent spin-off of its water-and-packaging business Veralto (more on that split below). To be sure, the IPO market for Danaher's key biotech customers hasn't fully opened yet, and the China market remains an overhang. But we think both issues will eventually subside, so we're holding onto our DHR shares. Disney (DIS): The time to buy Disney is now, Jim said. We're glad activist investor Nelson Peltz decided to revive his pressure on Disney management, given the stock's dramatic underperformance. Significant decisions loom around the future of ESPN and the need to acquire the rest of streaming service Hulu from CNBC parent company Comcast (CMSCA). Peltz has successfully pushed for accountability at other companies, and Disney should welcome his involvement, not rebuff it. Estee Lauder (EL): Patience is still required with Estee Lauder, but Jim is confident that CEO Fabrizio Freda will be able to surmount recent inventory obstacles in the cosmetics giant's key Asian travel retail business. Emerson Electric (EMR): Emerson on Wednesday completed its $8.2 billion acquisition of National Instruments, which should help grow the industrial automation firm's earnings. In general, our outlook on Emerson has improved since the spring. Over the past six months, the stock has rallied more than 14%, narrowly outperforming the S & P 500 over that time. Ford Motor (F): Jim expressed confidence in Ford CEO Jim Farley, as the targeted United Auto Workers strike approaches the one-month mark. Once those labor issues are resolved, Jim said Ford should be able to deliver quality earnings. Regardless, Ford is back to being a "one more quarter" situation, Jim said, which is t errain it occupied earlier this year after a messy fiscal 2022 fourth quarter print. Foot Locker (FL): Recent results from shoemakers Nike (NKE) and On Holding (ONON) have lifted Foot Locker's stock up more than 20% so far in October. Nevertheless, Jim said Foot Locker and CEO Mary Dillon remain in a race against time to turn its business around. We have a 4 rating on the stock. GE Healthcare (GEHC): The medical equipment giant is the most undervalued holding in our entire portfolio, after its more than 16% decline over the past three months, according to Jim. Spun out of General Electric (GE) in January, GEHC is investing in innovation and stands to gain from the rollout of Alzheimer's therapies that target plaque on the brain. It makes the machines needed to screen those patients. Alphabet (GOOGL): The technology giant has addressed many of the concerns we held earlier in the year around costs and its AI strategy. At this point, Jim said management just needs to keep doing what it's been doing lately. Google faces two major government antitrust lawsuits, one of which went to a trial recently and is still ongoing. Honeywell International (HON): The industrial conglomerate on Tuesday announced a business restructuring and reaffirmed its third-quarter earnings per share guidance. The restructuring orients Honeywell around what it called the three "compelling megatrends" of automation, the future of aviation, and energy transition. Jim stressed that we're willing to give newly installed CEO Vimal Kapur time to make his mark on the firm. Humana (HUM): On Friday, we made good on our pledge to trim Humana when it returned to $500 per share. This stock became a battle in June when medical cost worries emerged in June, but the worst of those fears are now in the past . The stock is down Wednesday after Humana announced longtime CEO Bruce Broussard will step down in the second half of 2024. We're fans of Broussard, and he will be missed. We expect to hear more of the next CEO's plans on the upcoming earnings call, which is set for Nov. 1. Linde (LIN): Going forward, Jim said he's going to be more deliberate in recommending Linde's stock on pullbacks. They don't happen all that often, he said, so when they do it's worth taking advantage of. Linde, a so-called Dividend Aristocrat , has pricing power and exposure to high-quality end markets such as health care, semiconductors and clean energy initiatives . Eli Lilly (LLY): After a multiweek slide in September, Eli Lilly has returned to its winning ways and is on track to close at a fresh all-time high Wednesday amid additional optimism around the medical benefits that drugs in the GLP-1 category could deliver. Lilly's diabetes drug Mounjaro, which may soon be approved to also treat obesity, is in the GLP-1 class. More generally, we're pleased with the manufacturing investments Lilly has been making. Meta Platforms (META): The social media giant has righted the ship in this "year of efficiency," and Jim said CEO Mark Zuckerberg should keep the vessel sailing on this new course. We should hear more about the firm's latest AI offerings and the rebound in advertising in two weeks when Meta reports earnings. Morgan Stanley (MS): Jim acknowledged he's been mystified by Morgan Stanley's stock performance, down nearly 7% over the past three months and in all of 2023. Even with CEO James Gorman set to retire soon, we remain confident in the asset-and-wealth management focus that he's ushered in. But that model may not be enough to get the stock moving higher. Increasingly, Jim said, he thinks an end to the Federal Reserve's tightening cycle may be the only thing to put an end to credit fears and really spark a rally in bank stocks. Morgan Stanley is set to report earnings next week. Microsoft (MSFT): After an 11-week stretch in which Microsoft suffered weekly losses in all but three, signs recently emerged that the stock could be primed to erupt. Last week, the stock rose nearly 3.65% and is on pace for additional gains this week. Large customers will be able to purchase the tech giant's AI assistant software beginning Nov. 1. Nvidia (NVDA): The king of AI chips remains our other "own it, don't trade it" stock. (Remember, Apple is the other). Nvidia maintains a substantial lead in the generative AI race, despite chatter that suggests the contrary, Jim said. Nvidia's AI chips, which excel in training the large-large models that power apps like ChatGPT, are still in high demand at cloud-computing giants like Microsoft, he said. Oracle (ORCL): Oracle is at a great level to buy, Jim said, noting that its stock trades at a low multiple relative to other large cloud-computing providers, such as Microsoft and Amazon. To be sure, investors are worried Oracle paid too much for medical records firm Cerner, which has proven to be an overhang lately. But we remain bullish on Oracle's AI-fueled cloud growth. Palo Alto Networks (PANW): After a number of corporations were hit by cyberattacks, there is renewed attention on the importance of information technology security. Jim said Palo Alto Networks stands out for its ability to offer a range of security features on the same platform. Shares of PANW are trading at all-time highs Wednesday. Procter & Gamble (PG): This might not be the best stock for an economic boom, but enough investors are worried about a recession that P & G shares should be able to move higher if the bond market settles down. While many consumer staple companies that sell food have been hit lately on worries about the business impact from those new GLP-1 weight-loss/diabetes drugs, Jim noted that P & G's portfolio of grooming, cleaning and personal health products is above the fray. Pioneer Natural Resources (PXD): Now that Exxon's all-stock deal for Pioneer has been announced, we intend to sell our PXD position as soon our trading rules allow. We had hoped Exxon would pay a higher premium for Pioneer. But in any case, we want to lock in profits on the 300 Pioneer shares we still own and not wait for the deal to close . Reflecting our intentions, we downgraded the stock to our 3 rating. Starbucks (SBUX): Jim expects Starbucks' business to soon enter a new phase of acceleration, and urged investors to take on additional shares of the coffee chain before other market participants realize that's happening. Under new CEO Laxman Narasimhan, there is still growth to be had in U.S. and China, the company's two largest markets, Jim contended. Constellation Brands (STZ): Investors should buy Constellation ahead of its Investor Day event on Nov. 2 . That's when we expect to hear a strategy update influenced by activist investment firm Elliott Management. While the market has been worrying about the impact new weight-loss drugs could have on the food-and-beverage industry , Constellation's Mexican beer portfolio is well-positioned to keep growing. Stanley Black & Decker (SKW): After a few quarters of per-share losses, the tool maker is on track to return to profitability in its September quarter, and earnings next year are projected to exceed 2022 levels, according to estimates compiled by FactSet. In other words, the turnaround story that attracted us to the stock in the first place is well on its way. TJX Companies (TJX): The parent company of T.J. Maxx, Marshalls and HomeGoods heads into the busy holiday shopping season on fertile ground. Even with a nearly 12% gain so far this year, Jim said he sees additional upside ahead for the stock. Plus, he noted that Piper Sandler's biannual teen survey indicated TJX was seeing momentum with young shoppers. Veralto (VLTO): Veralto is the newly public entity consisting of Danaher's aforementioned water-and-packaging business. As discussed before , we decided to keep the Veralto shares we received as part of the spin-off transaction because we see plenty to like about its fundamentals, especially now that management can run the firm outside the walls of a larger corporate structure. While the stock has trended lower since it began trading this month, that kind of action is typical in a spin-off as Danaher shareholders who are uninterested in VLTO offload their positions. Wells Fargo (WFC): We're hoping to learn Friday that Wells Fargo is willing to step up the pace of its stock repurchases, when the bank reports its third-quarter earnings before the opening bell. At a conference in September, the bank's CFO indicated buybacks in Q3 slowed compared with the first half of the year. The same industry headwinds weighing on Morgan Stanley are hitting Wells Fargo, too. Wynn Resorts (WYNN): Despite strength at its U.S. properties in Las Vegas and Boston, Wynn Resorts is ultimately driven by what happens in Macau, the Chinese special administrative region and marquee gaming hub of Asia. Lately, with concerns about the health of China's economy abound, Wynn's stock has dropped nearly 12% over the past three months. At this point, though, we would be more of a buyer here than a seller. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

CNBC Investing Club with Jim Cramer

Rob Kim | NBCUniversal

Here's a rapid-fire update on all stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. Jim ran through each stock Wednesday during our October Monthly Meeting.